Pleschka S - Search Results

1

Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses.

Scheibner D, Salaheldin AH, Bagato O, Zaeck LM, Mostafa A, Blohm U, Müller C, Eweas AF, Franzke K, Karger A, Schäfer A, Gischke M, Hoffmann D, Lerolle S, Li X, Abd El-Hamid HS, Veits J, Breithaupt A, Boons GJ, Matrosovich M, Finke S, Pleschka S, Mettenleiter TC, de Vries RP, Abdelwhab EM. Scheibner D, et al. Among authors: pleschka s. PLoS Pathog. 2023 Feb 6;19(2):e1011135. doi: 10.1371/journal.ppat.1011135. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36745654 Free PMC article.

2

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.

Planz O, Pleschka S, Ludwig S. Planz O, et al. Among authors: pleschka s. J Virol. 2001 May;75(10):4871-7. doi: 10.1128/JVI.75.10.4871-4877.2001. J Virol. 2001. PMID: 11312358 Free PMC article.

3

The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, García-Sastre A, Heins G, Wolff T. Ludwig S, et al. Among authors: pleschka s. J Virol. 2002 Nov;76(21):11166-71. doi: 10.1128/jvi.76.21.11166-11171.2002. J Virol. 2002. PMID: 12368362 Free PMC article.

4

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation.

Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, Planz O, Ludwig S. Wurzer WJ, et al. Among authors: pleschka s. J Biol Chem. 2004 Jul 23;279(30):30931-7. doi: 10.1074/jbc.M403258200. Epub 2004 May 12. J Biol Chem. 2004. PMID: 15143063 Free article.

5

Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication.

Bourteele S, Oesterle K, Pleschka S, Unterstab G, Ehrhardt C, Wolff T, Ludwig S, Planz O. Bourteele S, et al. Among authors: pleschka s. J Virol. 2005 May;79(10):6043-51. doi: 10.1128/JVI.79.10.6043-6051.2005. J Virol. 2005. PMID: 15857990 Free PMC article.

6

Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice.

Olschläger V, Pleschka S, Fischer T, Rziha HJ, Wurzer W, Stitz L, Rapp UR, Ludwig S, Planz O. Olschläger V, et al. Among authors: pleschka s. Oncogene. 2004 Aug 26;23(39):6639-46. doi: 10.1038/sj.onc.1207883. Oncogene. 2004. PMID: 15235583

7

A plasmid-based reverse genetics system for influenza A virus.

Pleschka S, Jaskunas R, Engelhardt OG, Zürcher T, Palese P, García-Sastre A. Pleschka S, et al. J Virol. 1996 Jun;70(6):4188-92. doi: 10.1128/JVI.70.6.4188-4192.1996. J Virol. 1996. PMID: 8648766 Free PMC article.

8

An inducible T7 RNA polymerase-dependent plasmid system.

Hamdorf M, Muckenfuss H, Tschulena U, Pleschka S, Sanzenbacher R, Cichutek K, Flory E. Hamdorf M, et al. Among authors: pleschka s. Mol Biotechnol. 2006 May;33(1):13-21. doi: 10.1385/mb:33:1:13. Mol Biotechnol. 2006. PMID: 16691002

9

The vesicular stomatitis virus matrix protein inhibits glycoprotein 130-dependent STAT activation.

Terstegen L, Gatsios P, Ludwig S, Pleschka S, Jahnen-Dechent W, Heinrich PC, Graeve L. Terstegen L, et al. Among authors: pleschka s. J Immunol. 2001 Nov 1;167(9):5209-16. doi: 10.4049/jimmunol.167.9.5209. J Immunol. 2001. PMID: 11673534

10

Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3.

Ehrhardt C, Kardinal C, Wurzer WJ, Wolff T, von Eichel-Streiber C, Pleschka S, Planz O, Ludwig S. Ehrhardt C, et al. Among authors: pleschka s. FEBS Lett. 2004 Jun 4;567(2-3):230-8. doi: 10.1016/j.febslet.2004.04.069. FEBS Lett. 2004. PMID: 15178328 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page